Liposomal ● Doble aplicación

Liposomal NMNH

Produced via enzymatic reduction of NMN; found naturally in trace amounts in mammalian cells as a reduced coenzyme metabolite

Pureza 98%
Número CAS 108347-85-9
Constituyente Activo Reduced Nicotinamide Mononucleotide (NMNH)

Liposomal NMNH (Reduced Nicotinamide Mononucleotide) — a next-generation NAD+ precursor that bypasses rate-limiting enzymes for faster and more potent cellular rejuvenation in anti-aging formulations.

Especificación disponible:
🌿
Vía tópica Grado cosmético (registrado en INCI)
💊
Vía oral Grado alimentario / nutracéutico al por mayor

Reduced Nicotinamide Mononucleotide (NMNH) — Liposomal Bulk Raw Material for Anti-Aging & Beauty

Liposomal NMNH represents the reduced form of nicotinamide mononucleotide, offering a more efficient pathway to NAD+ replenishment than conventional NMN. The additional hydrogen atoms in NMNH allow it to bypass certain rate-limiting enzymatic steps, resulting in significantly faster intracellular NAD+ elevation and enhanced sirtuin activation. This novel ingredient is poised to become a breakthrough in next-generation longevity cosmetics and oral beauty supplements.

Available Purity Grades

  • Reduced Nicotinamide Mononucleotide 98% (HPLC) — Liposomal powder with phosphatidylcholine encapsulation for enhanced bioavailability.

Why Choose Our Liposomal Reduced Nicotinamide Mononucleotide?

  • Superior NAD+ Elevation: NMNH raises intracellular NAD+ levels more rapidly and to a higher magnitude than equivalent doses of NMN, making it the most efficient NAD+ precursor currently available.
  • Bypass Rate-Limiting Enzymes: The reduced nicotinamide ring in NMNH circumvents the NAMPT-catalyzed rate-limiting step, enabling faster conversion to NAD+ without competing with endogenous nicotinamide.
  • Enhanced PARP Activity: By maintaining higher NAD+ pools, NMNH supports continuous PARP-mediated DNA repair in skin cells exposed to chronic UV and environmental stressors.
  • Sirtuin Power Boost: NMNH-derived NAD+ preferentially activates SIRT3 in mitochondria, boosting oxidative metabolism in dermal fibroblasts and promoting collagen matrix deposition.
  • Liposomal Redox Protection: Phospholipid encapsulation protects the chemically sensitive reduced form from oxidation during storage and transit, ensuring the active NMNH reaches target tissues intact.
  • Next-Generation Positioning: As a cutting-edge NAD+ precursor, NMNH offers brands a unique differentiator in the competitive anti-aging and longevity ingredient market.

Target Applications

  • Clinical-Grade Longevity Brands: Anti-aging companies seeking the most advanced NAD+ precursor for premium, science-backed formulations that outperform NMN-based products in clinical trials.
  • Biohacking & Wellness Innovators: Brands targeting sophisticated consumers who track biomarkers and demand the newest, most potent longevity compounds available on the market.

Quality & Compliance

  • GMP-certified production facilities
  • Liposomal encapsulation verified by DLS particle size analysis
  • COA provided with every shipment
  • Heavy metals compliant (Pb ≤ 2 ppm, As ≤ 1 ppm)
  • Custom packaging and private labeling available
  • Stable shelf life: 24 months (cool, dry storage, protected from light)

Bulk Supply & OEM Service

We supply liposomal Reduced Nicotinamide Mononucleotide in bulk quantities (sample to 25 kg drums) for B2B buyers, contract manufacturers, and private-label brands. Contact our technical team for quotes, sample requests, or formulation consultation.

Preguntas frecuentes

Solicitar cotización o muestra

Envíe su consulta y nuestro representante comercial se pondrá en contacto con usted en un plazo de 24 horas.

Ir al formulario de consulta →